Blog
Follow us for the latest trends, insights and innovations in the pharmaceutical industry.
Cardiovascular Drug Intermediates: In-Depth Analysis of Key Compounds and Market Demand
Explore key pharmaceutical intermediates for cardiovascular drugs, manufacturing requirements, and global market demand supported by regulatory and industry data.
Read More →
Crystallization & Solid Form Challenges for Intermediates
Crystallization and solid-form control are critical to intermediate quality, scalability, and downstream API performance. This article explores common solid-state challenges, scale-up risks, and why early ...
Read More →
Orforglipron: A New Oral GLP-1 Option Redefining Weight Management
Orforglipron is Eli Lilly’s oral GLP-1 receptor agonist for weight management, currently under FDA review. This article examines its clinical background, weight-maintenance data, and implications ...
Read More →
Batch-to-Batch Consistency: Why It Matters for Intermediates
Learn why batch-to-batch consistency is critical for pharmaceutical intermediates, impacting impurity control, scale-up success, and regulatory compliance.
Read More →